THE BUSINESS OF BIOTECH

32:40 24_01_BoB_1280x720_Ep261
BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies

This week's episode is one from the road, recorded in front of a live audience in Boston's Seaport neighborhood during the BIO conference (special thanks to MasterControl for making it happen). Amber Salzman, Ph.D., CEO of Epicrispr Biotechnologies (aka 'Epic ...

ABOUT THE BUSINESS OF BIOTECH

Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.

FEATURED GUESTS

Amber Salzman
Epicrispr Biotechnologies
PLAY
Jennifer Hawks Bland
NewYorkBIO
PLAY
Barry Quart
Connect Biopharma
PLAY
Srinivas Rao
atai Life Sciences
PLAY
Yaniv Sneor
Native State Therapeutics
PLAY
Michelle Werner
Alltrna
PLAY
Mark Eisner
Vir Biotechnology
PLAY
Tolga Tanguler
Alnylam Pharmaceuticals
PLAY

MEET YOUR HOST

Ben ComerBen Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute.

Interested in joining us on air? Contact us